Clal Biotechnology

A leading Israeli life sciences investment company focused on biotech, pharma, diagnostics, and medical devices.

Holding Company Tel Aviv, Israel Est. 1993
Visit website ↗ LinkedIn
Last updated 2026-11-03
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$18.0M
total disclosed, rounds participated
Stages
Seed, Early Stage, Growth, Late Stage, Initial Revenues, R&D, Revenue Growth

About

Clal Biotechnology Industries (CBI) is Israel's largest life sciences investment company, traded on the Tel Aviv Stock Exchange (TASE: CBI). CBI identifies and supports promising innovative ventures, developing proprietary solutions to address unmet medical needs with multibillion-dollar market potential. CBI invests in companies ranging from seed to maturity, both public and private, applying diverse models of strategic cooperation, providing significant investments together with hands-on leadership and guidance.

Portfolio · 1

MediWound
A biopharmaceutical company focused on developing and commercializing enzymatic therapies for non-surgical tissue repair.
1 round $18.0M committed Latest: 2013-06
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)